Łukasz Galus
7PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 05, 2024
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.Natalia Szóstak, Luiza Handschuh, Anna Samelak-Czajka
|Sep 09, 2023
Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report.Joanna Placzke, Magdalena Rosińska, Paweł Sobczuk
|Apr 24, 2023
Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD-1 therapy.Łukasz Galus, Michał Michalak, Mateusz Lorenz
|Mar 29, 2023
Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients.Paula Kamińska, Karolina Buszka, Łukasz Galus
|Mar 11, 2023
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy.Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus
|Nov 11, 2022
A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition.Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik-Schmidt
Pageof 2
Frequent Collaborators
3 joint publications
Marcin Schmidt
3 joint publications
Andrzej Mackiewicz
3 joint publications
Katarzyna Tomela
3 joint publications
Bernadeta Pietrzak
2 joint publications
Bożena Cybulska-Stopa
2 joint publications
Grażyna Kamińska-Winciorek
2 joint publications
Marcin Ziętek
2 joint publications
Mariusz Kaczmarek
1 joint publications
Anna M Czarnecka
1 joint publications
Karolina Piejko
